Genomic screening can facilitate early detection of thyroid cancer in patients with RET gene variants

Population-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene, a new Geisinger study found.

Related Keywords

,Adam Buchanan ,Nicholas Purdy ,Emily Henderson ,Mycode Community Health Initiative ,Geisinger Department Of Genomic Health ,Geisinger Department ,Mycode Community Health ,Genomic Health ,Cancer ,Enomic ,Thyroid ,Thyroid Cancer ,Gene ,Enetic ,Neck ,Otolaryngology ,Research ,Surgery ,Thyroidectomy ,